Nutlin-3 downregulates p53 phosphorylation on serine(392) and induces apoptosis in hepatocellular carcinoma cells

Drug-resistance and imbalance of apoptotic regulation limit chemotherapy clinical application for the human hepatocellular carcinoma (HCC) treatment. The reactivation of p53 is an attractive therapeutic strategy in cancer with disrupted-p53 function. Nutlin-3, a MDM2 antagonist, has antitumor activi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Shi, Xinli, Liu, Jingli, Ren, Laifeng, Mao, Nan, Tan, Fang, Ding, Nana, Yang, Jing, Li, Mingyuan
Format: Artigo
Idioma:Inglês
Publicat: Korean Society for Biochemistry and Molecular Biology 2014
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4163890/
https://ncbi.nlm.nih.gov/pubmed/24286312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5483/BMBRep.2014.47.4.146
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars